11:00 CET

Webcast – present and explain melflufen’s mechanism of action

Oncopeptides will host a webcast on Monday, January 27th 2020 were CEO Jakob Lindberg will present and explain melflufen’s mechanism of action.

 

Conference call for investors, analysts and the media, Monday, January 27th 2020, at 11 (CET)

 

Phone numbers for participants from:
Sweden: +46 8 56642651
Europe: +44 6319131422
USA: +1 3333000804

Participant Pin code
PIN: 84274870#

The conference call will also be streamed via the link below:
https://tv.streamfabriken.com/2020-01-27-oncopeptides-press-conference

The presentation will be available under Presentations just before the start of the webcast:
www.oncopeptides.com / Investor Relations / Presentations / Presentation webcast melflufen mechanism-of-action/

Upcoming events

Annual General Meeting 2022

The Annual General Meeting in Oncopeptides AB (publ) will be held on Tuesday June 28, 2022, (changed from May 19, 2022) in Stockholm, Sweden. Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Annual General Meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Annual General Meeting will be held without physical presence.

Silent Period

-

Silent Period

-

Silent Period

-

Year-end report 2022

08:00 CET